Hasil Pencarian - Yijun Jia
- Menampilkan 1 - 10 hasil dari 10
-
1
-
2
-
3
An Experimental Analysis of the Molecular Effects of Trastuzumab (Herceptin) and Fulvestrant (Falsodex), as Single Agents or in Combination, on Human HR+/HER2+ Breast Cancer Cell L... oleh Qing Chen, Ziyi Weng, Yunshu Lu, Yijun Jia, Longlong Ding, Fang Bai, Meixin Ge, Qing Lin, Kejin Wu
Diterbitkan 2017-01-01Dapatkan teks lengkap
Artikel -
4
Oxygen-carbon nanotubes as a chemotherapy sensitizer for paclitaxel in breast cancer treatment. oleh Yongkun Wang, Chuanying Wang, Yijun Jia, Xianhua Cheng, Qing Lin, Mingjie Zhu, Yunshu Lu, Longlong Ding, Ziyi Weng, Kejin Wu
Diterbitkan 2014-01-01Dapatkan teks lengkap
Artikel -
5
-
6
Mutation landscape in Chinese nodal diffuse large B-cell lymphoma by targeted next generation sequencing and their relationship with clinicopathological characteristics oleh Bing Cao, Chenbo Sun, Rui Bi, Zebing Liu, Yijun Jia, Wenli Cui, Menghong Sun, Baohua Yu, Xiaoqiu Li, Xiaoyan Zhou
Diterbitkan 2024-04-01Dapatkan teks lengkap
Artikel -
7
Osimertinib in combination with anti-angiogenesis therapy presents a promising option for osimertinib-resistant non-small cell lung cancer oleh Ruoshuang Han, Haoyue Guo, Jinpeng Shi, Sha Zhao, Yijun Jia, Xiaozhen Liu, Yiwei Liu, Lei Cheng, Chao Zhao, Xuefei Li, Caicun Zhou
Diterbitkan 2024-04-01Dapatkan teks lengkap
Artikel -
8
Correction: Osimertinib in combination with anti-angiogenesis therapy presents a promising option for osimertinib-resistant non-small cell lung cancer oleh Ruoshuang Han, Haoyue Guo, Jinpeng Shi, Sha Zhao, Yijun Jia, Xiaozhen Liu, Yiwei Liu, Lei Cheng, Chao Zhao, Xuefei Li, Caicun Zhou
Diterbitkan 2024-09-01Dapatkan teks lengkap
Artikel -
9
Interleukin-10 induces expression of CD39 on CD8+T cells to potentiate anti-PD1 efficacy in EGFR-mutated non-small cell lung cancer oleh Lei Cheng, Caicun Zhou, Tao Jiang, Fei Zhou, Shengxiang Ren, Hongcheng Liu, Xinyu Liu, Xiaoxia Chen, Xuefei Li, Chao Zhao, Meng Qiao, Haowei Wang, Yijun Jia
Diterbitkan 2022-12-01Dapatkan teks lengkap
Artikel -
10
Patients With Short PFS to EGFR-TKIs Predicted Better Response to Subsequent Anti-PD-1/PD-L1 Based Immunotherapy in EGFR Common Mutation NSCLC oleh Sangtian Liu, Fengying Wu, Xuefei Li, Chao Zhao, Yijun Jia, Keyi Jia, Ruoshuang Han, Meng Qiao, Wei Li, Jia Yu, Fei Zhou, Anwen Xiong, Bin Chen, Jue Fan, Shengxiang Ren, Caicun Zhou
Diterbitkan 2021-03-01Dapatkan teks lengkap
Artikel